Planned Parenthood and the American Medical Association have become the latest groups to sue the Trump administration over rule changes to Title X; an Ohio teen testified before a Senate committee about why he defied his mom and get vaccinated; and a federal judge has ruled that a unit of UnitedHealth Group had implemented policies discriminating against patients with mental health and substance abuse disorders.
Following the lead of California, Planned Parenthood and the American Medical Association (AMA) have filed a lawsuit against the Trump administration over rule changes to Title X, reported The Hill. Under the rule changes, Planned Parenthood is expected to lose $60 million in funding. A statement from AMA President Barbara McAneny, MD, said the changes will prohibit physicians from having open and frank conversations with their patients about all of their options, which is a violation of patients’ rights under the Code of Ethics.Ethan Lindenberger of Norwalk, Ohio, appeared before the Senate Committee on Health, Education, and Labor on Tuesday to talk about why he defied his mom’s anti-vaccination beliefs and got vaccinated. Pointing to social media, Lindenberger warned of fraudulent claims circulating on the platforms, particularly Facebook. According to NPR, he told the committee that organized groups spreading these claims should be the primary concern of the American people.A federal judge in Northern California has ruled that United Behavioral Health, a unit of UnitedHealth Group, had implemented internal policies that led to the discrimination against patients with mental health and substance abuse disorders in order to save money. The New York Times has reported that in a 106-page decision, the judge claimed there was excessive emphasis placed upon treating acute symptoms and ignoring effective treatment of underlying conditions. Once patients appeared to be stable, they were denied care.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More